ConductScience.org, home

Paper41525337

Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions.

Beauchemin KS and 8 others. PLoS Pathog, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions. Papers, record 41525337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41525337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions.
PubMed
Journal
PLoS Pathog
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-10-25
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beauchemin KSKathryn S
2Kun JJudit
3Groveman BBradley
4Williams KKatie
5Salerno FFrancesca
6Francomacaro LMLisa M
7Robison PPatrick
8Haigh CLCathryn L
9Supattapone SSurachaihttps://orcid.org/0000-0001-9060-4550

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HexosyltransferasesMajor topic
Membrane ProteinsMajor topic
Prion DiseasesMajor topic
PrionsMajor topic
Humans
Animals
Mice
Glycosylation
Enzyme Inhibitors

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P20 GM113132NIGMS NIH HHSUnited StatesP20GM113132PubMedNIH RePORTER
T32 AI007519NIAID NIH HHSUnited StatesT32AI007519PubMedNIH RePORTER
R37 NS125431NINDS NIH HHSUnited StatesR37NS125431PubMedNIH RePORTER
R01 NS118796NINDS NIH HHSUnited StatesR01NS118796PubMedNIH RePORTER
R01 NS117276NINDS NIH HHSUnited StatesR01NS117276PubMedNIH RePORTER

Download CSV of grants

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18003954Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.Protein Sci1994https://conductscience.org/library/papers/8003954PubMed
222743772Fiji: an open-source platform for biological-image analysis.Nat Methods2012https://conductscience.org/library/papers/22743772PubMed
334904943Alternating anti-prion regimens reduce combination drug resistance but do not further extend survival in scrapie-infected mice.J Gen Virol2021https://conductscience.org/library/papers/34904943PubMed
417115708The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro.Biochemistry2006https://conductscience.org/library/papers/17115708PubMed
52574992Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein.Biochemistry1989https://conductscience.org/library/papers/2574992PubMed
629924488Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons.Curr Protoc Cell Biol2018https://conductscience.org/library/papers/29924488PubMed
723408888Acquisition of drug resistance and dependence by prions.PLoS Pathog2013https://conductscience.org/library/papers/23408888PubMed
823583305N-linked protein glycosylation in the ER.Biochim Biophys Acta2013https://conductscience.org/library/papers/23583305PubMed
923604588Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.Acta Neuropathol2013https://conductscience.org/library/papers/23604588PubMed
1019278902Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.Lancet Neurol2009https://conductscience.org/library/papers/19278902PubMed
1133444414Short and sweet: How glycans impact prion conversion, cofactor interactions, and cross-species transmission.PLoS Pathog2021https://conductscience.org/library/papers/33444414PubMed
129122195COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9122195PubMed
1323965382Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice.J Pharmacol Exp Ther2013https://conductscience.org/library/papers/23965382PubMed
1437156804Glycosylation and behavioral symptoms in neurological disorders.Transl Psychiatry2023https://conductscience.org/library/papers/37156804PubMed
158552188Normal host prion protein necessary for scrapie-induced neurotoxicity.Nature1996https://conductscience.org/library/papers/8552188PubMed
164206342Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.Infect Immun1973https://conductscience.org/library/papers/4206342PubMed
1710409615Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions.J Biol Chem1999https://conductscience.org/library/papers/10409615PubMed
1821152012Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.PLoS Pathog2010https://conductscience.org/library/papers/21152012PubMed
1911470893Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11470893PubMed
2032776089Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints.Nucleic Acids Res2020https://conductscience.org/library/papers/32776089PubMed

See all 97 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42842018From a prion seed to a tree of discoveries: Byron Caughey's RT-QuIC legacy in protein misfolding research.Acta Neuropathol2026https://conductscience.org/library/papers/42842018PubMed
42762360Life at the interface: Byron Caughey's search for prion disease inhibitors through chemistry, structure, and cell physiology.Acta Neuropathol2026https://conductscience.org/library/papers/42762360PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DDOST1650PubTator's text mininghttps://conductscience.org/library/genes/1650NCBI Gene
PRNP5621PubTator's text mininghttps://conductscience.org/library/genes/5621NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41525337

GET https://conductscience.org/api/papers/v1/41525337/references?page=2